Marilys Corbex: On the Side of the People
BCG Plus Immunotherapy Shows Modest Recurrence Benefit but Higher Toxicity in BCG-Naïve High-Risk NMIBC
Wafik El-Deiry: Scientific Freedom and Diverse Thinking Drive Better Medicine
CLARITY-Gastric01: Sonesitatug Vedotin Improves Overall Survival in 2L+ CLDN18.2-Positive Advanced Gastric/GEJ Cancers
Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring
Herbert Loong: Prospective Open-labelled Phase 2 Pembrolizumab in Acral Lentiginous Melanoma
SABCS 2026 Male Breast Cancer Advocate Scholarship
RxPONDER Analysis: Ovarian Reserve May Refine Chemotherapy Decisions in HR-Positive Breast Cancer
